Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula
Neuroentwicklungsoutcomes extrem frühgeborener Säuglinge bei Ernährung mit Spenderinnenmilch oder Frühgeborenennahrung
JAMA · 20.02.2024 · 331 (7) · 582
DOI: 10.1001/jama.2023.27693 ↗Auf einen Blick
Bei extrem frühgeborenen Säuglingen mit minimaler mütterlicher Milch unterschieden sich die Neuroentwicklungsoutcomes mit Spenderinnenmilch und Frühgeborenennahrung mit 22 bis 26 Monaten korrigiertem Alter nicht.
Fragestellung
Verbessert angereicherte, pasteurisierte Spenderinnenmilch im Vergleich zu Frühgeborenennahrung die Neuroentwicklungsoutcomes mit 22 bis 26 Monaten korrigiertem Alter?
Methode
Doppelt verblindete randomisierte klinische Studie an 15 US-Zentren. Einschluss zwischen September 2012 und März 2019; Ernährung bis 120 Tage, Tod oder Entlassung.
Ergebnisse
483 Säuglinge randomisiert (239 Spenderinnenmilch, 244 Frühgeborenennahrung). BSID-Kognitionsscore: 80,7 vs. 81,1; adjustierte mittlere Differenz −0,77 (95 %-KI −3,93 bis 2,39). NEC: 4,2 % vs. 9,0 %; adjustierte Risikodifferenz −5 % (95 %-KI −9 % bis −2 %).
Schlussfolgerung der Autor:innen
Bei extrem frühgeborenen Neugeborenen mit minimaler mütterlicher Milch unterschieden sich die Neuroentwicklungsoutcomes mit 22 bis 26 Monaten korrigiertem Alter nicht zwischen Spenderinnenmilch und Frühgeborenennahrung.
Kernaussagen
- Kein Unterschied im BSID-Kognitionsscore nach 22 bis 26 Monaten
- NEC trat unter Spenderinnenmilch seltener auf
- Die Gewichtszunahme war in der Spenderinnenmilchgruppe langsamer
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 20.02.2024. Verfasst von Tarah T Colaizy und 57 weiteren Autor:innen. Beteiligte Einrichtung: Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City. Hauptthemen laut MEDLINE: Milk, Human, Enterocolitis, Necrotizing. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Themen: Neonatologie
Abstract (Originalsprache)
Importance Maternal milk feeding of extremely preterm infants during the birth hospitalization has been associated with better neurodevelopmental outcomes compared with preterm formula. For infants receiving no or minimal maternal milk, it is unknown whether donor human milk conveys similar neurodevelopmental advantages vs preterm formula.
Objective
To determine if nutrient-fortified, pasteurized donor human milk improves neurodevelopmental outcomes at 22 to 26 months’ corrected age compared with preterm infant formula among extremely preterm infants who received minimal maternal milk. Design, Setting, and Participants Double-blind, randomized clinical trial conducted at 15 US academic medical centers within the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Infants younger than 29 weeks 0 days’ gestation or with a birth weight of less than 1000 g were enrolled between September 2012 and March 2019.
Intervention
Preterm formula or donor human milk feeding from randomization to 120 days of age, death, or hospital discharge. Main Outcomes and Measures The primary outcome was the Bayley Scales of Infant and Toddler Development (BSID) cognitive score measured at 22 to 26 months’ corrected age; a score of 54 (score range, 54-155; a score of ≥85 indicates no neurodevelopmental delay) was assigned to infants who died between randomization and 22 to 26 months’ corrected age. The 24 secondary outcomes included BSID language and motor scores, in-hospital growth, necrotizing enterocolitis, and death.
Results
Of 1965 eligible infants, 483 were randomized (239 in the donor milk group and 244 in the preterm formula group); the median gestational age was 26 weeks (IQR, 25-27 weeks), the median birth weight was 840 g (IQR, 676-986 g), and 52% were female. The birthing parent’s race was self-reported as Black for 52% (247/478), White for 43% (206/478), and other for 5% (25/478). There were 54 infants who died prior to follow-up; 88% (376/429) of survivors were assessed at 22 to 26 months’ corrected age. The adjusted mean BSID cognitive score was 80.7 (SD, 17.4) for the donor milk group vs 81.1 (SD, 16.7) for the preterm formula group (adjusted mean difference, −0.77 [95% CI, −3.93 to 2.39], which was not significant); the adjusted mean BSID language and motor scores also did not differ. Mortality (death prior to follow-up) was 13% (29/231) in the donor milk group vs 11% (25/233) in the preterm formula group (adjusted risk difference, −1% [95% CI, −4% to 2%]). Necrotizing enterocolitis occurred in 4.2% of infants (10/239) in the donor milk group vs 9.0% of infants (22/244) in the preterm formula group (adjusted risk difference, −5% [95% CI, −9% to −2%]). Weight gain was slower in the donor milk group (22.3 g/kg/d [95% CI, 21.3 to 23.3 g/kg/d]) compared with the preterm formula group (24.6 g/kg/d [95% CI, 23.6 to 25.6 g/kg/d]). Conclusions and Relevance Among extremely preterm neonates fed minimal maternal milk, neurodevelopmental outcomes at 22 to 26 months’ corrected age did not differ between infants fed donor milk or preterm formula. Trial Registration ClinicalTrials.gov Identifier: NCT01534481
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City.
- Department of Pediatrics, Children's Healthcare of Atlanta, School of Medicine, Emory University, Atlanta, Georgia.
- Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina.
- Division of Neonatology, Heersink School of Medicine, University of Alabama, Birmingham.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center, Houston.
Förderung
- NICHD NIH HHS
Zitieren
APA
Colaizy, T. T., Poindexter, B. B., McDonald, S. A., Bell, E. F., Carlo, W. A., Carlson, S. J., DeMauro, S. B., Kennedy, K. A., Nelin, L. D., Sánchez, P. J., Vohr, B. R., Johnson, K. J., Herron, D. E., Das, A., Crawford, M. M., Walsh, M. C., Higgins, R. D., Stoll, B. J., Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, …, & Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (2024). Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula. JAMA, 331(7), 582. https://doi.org/10.1001/jama.2023.27693
Vancouver
Colaizy TT, Poindexter BB, McDonald SA, Bell EF, Carlo WA, Carlson SJ, et al. Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula. JAMA. 2024;331(7):582. doi:10.1001/jama.2023.27693
BibTeX
@article{Colaizy2024,
author = {Colaizy, Tarah T and Poindexter, Brenda B and McDonald, Scott A and Bell, Edward F and Carlo, Waldemar A and Carlson, Susan J and DeMauro, Sara B and Kennedy, Kathleen A and Nelin, Leif D and Sánchez, Pablo J and Vohr, Betty R and Johnson, Karen J and Herron, Dianne E and Das, Abhik and Crawford, Margaret M and Walsh, Michele C and Higgins, Rosemary D and Stoll, Barbara J and Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network and MILK Trial Investigators, MILK Trial Investigators and Ambalavanan, Namisavayam and Wyckoff, Myra H and D'Angio, Carl T and Bugg, George W and Ohls, Robin K and Reynolds, Anne Marie and Sokol, Gregory M and Laptook, Abbot R and Olsen, Steven L and White, Jessica R and Jadcherla, Sudarshan R and Bajaj, Monika and Parimi, Prabhu S and Schmidt, Barbara and Laughon, Matthew M and Barks, John and Fisher, Kimberley A and Hibbs, Anna Maria and Peralta-Carcelen, Myriam and Cook, Noah and Heyne, Roy J and Cavanaugh, Brenna and Adams-Chapman, Ira and Fuller, Janell and Hartley-McAndrew, Michelle E and Harmon, Heidi M and Duncan, Andrea F and Hines, Abbey C and Kilbride, Howard W and Richards, Laurie A and Maitre, Nathalie L and Natarajan, Girija and Trembath, Andrea N and Carlson, Martha D and Malcolm, William F and Wilson-Costello, Deanne E and MILK Trial Investigators, MILK Trial Investigators and Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network},
title = {Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula},
journal = {JAMA},
year = {2024},
volume = {331},
number = {7},
pages = {582},
doi = {10.1001/jama.2023.27693}
}
EUVIMED